Head & Neck Cancer Radiation Damage and HBOT

TL;DR: Radiation damage after head and neck cancer is a set of late complications that can develop months to years after curative radiotherapy. Osteoradionecrosis is a form of chronic, non-healing bone injury in the jaw or skull base that affects roughly 5% to 15% of head and neck cancer survivors treated with high-dose radiation. Alongside osteoradionecrosis, survivors frequently live with dry mouth (xerostomia), restricted jaw opening (trismus), soft-tissue radiation necrosis, dental breakdown, mucositis, dysphagia, and tissue fibrosis. Hyperbaric oxygen therapy is used both prophylactically (particularly before and after tooth extraction in irradiated jaws) and therapeutically (for established osteoradionecrosis and soft-tissue radiation necrosis) in coordinated oncology, dental, and hyperbaric medicine programmes across Canada. Evidence is strongest for the bone indications and mixed for the soft-tissue and mucosal issues. This Daffodil Month, we summarise what head and neck cancer radiation damage looks like, what the research shows about HBOT, and what Canadian patients need to know.

Estimated reading time: 12 minutes

What Is Radiation Damage After Head and Neck Cancer?

Head and neck cancers include cancers of the oral cavity, oropharynx, larynx, hypopharynx, nasopharynx, salivary glands, paranasal sinuses, and thyroid. Curative treatment almost always involves radiotherapy, often combined with chemotherapy and sometimes with surgery. Modern techniques such as intensity-modulated radiotherapy (IMRT), volumetric-modulated arc therapy (VMAT), and proton therapy have reduced but not eliminated collateral damage to surrounding tissues. Survival has improved over the past two decades, which means the population living with long-term radiation-related complications is larger than ever.

Radiation damage in this region is a spectrum, not a single diagnosis. The most clinically important late complications include:

Osteoradionecrosis (ORN) of the jaw: chronic, non-healing exposed bone of the mandible or, less often, maxilla
Skull-base osteoradionecrosis: a rarer but more serious form affecting the anterior and central skull base, usually after nasopharyngeal or paranasal sinus irradiation
Xerostomia: persistent dry mouth from radiation damage to the salivary glands
Trismus: restricted jaw opening from fibrosis of the muscles of mastication
Soft-tissue radiation necrosis: chronic wounds and ulceration of the oral mucosa, pharynx, or neck skin
Late dental breakdown: rapid tooth decay driven by dry mouth, reduced blood supply, and shifts in oral flora
Dysphagia and aspiration risk: fibrosis and nerve injury affecting swallowing
Cervical fibrosis and lymphoedema: visible and functional neck changes
Hearing, vestibular, and optic complications in skull-base and nasopharyngeal survivors

During Daffodil Month, the Canadian Cancer Society highlights the lived reality of cancer survivorship. Head and neck survivorship is, frankly, one of the most demanding: treatment is intense, and the late effects reshape daily life in ways that are visible, functional, and emotional.

Which Tissues Are Affected and How Often?

Complication	Typical onset after radiotherapy	Approximate rate in high-dose head/neck survivors
Xerostomia	Weeks to months, often persistent	Majority of survivors to some degree
Oral mucositis (late phase)	Often overlaps acute injury, can persist	Variable, commonly reported
Late dental decay	6 months onwards	High, particularly without fluoride prophylaxis
Trismus	3 to 12 months	Approximately 25% to 35% after high-dose IMRT
Osteoradionecrosis of the jaw	6 months to years	Approximately 5% to 15%, lower with IMRT
Skull-base osteoradionecrosis	Years, often delayed	Reported as a minority of nasopharyngeal survivors; much less common overall
Soft-tissue radiation necrosis (oral, pharyngeal, skin)	Months to years	Rates vary widely by site and dose
Dysphagia requiring intervention	6 months onwards	A meaningful minority; higher with concurrent chemoradiation
Cervical lymphoedema and fibrosis	Months to years	Common, with a broad severity range

The rates above come from Canadian and international cohorts using modern radiotherapy techniques. Incidence is lower with IMRT and proton therapy than with older conformal techniques, but non-zero. Canadian cancer centres routinely build long-term dental and hyperbaric follow-up into their head and neck survivorship pathways for this reason.

Who Is at Higher Risk?

Risk factors for head and neck radiation damage overlap across complications, which is why patients with one late effect often develop others. The most consistently reported factors include:

Higher cumulative dose, particularly to the mandible (above 60 Gy) or the skull base
Larger treated volume and less conformal technique
Concurrent chemoradiotherapy, especially platinum-based regimens
Tobacco and alcohol use during or after treatment
Pre-existing periodontal disease or unrestored teeth in the radiation field
Dental extractions in irradiated bone after treatment, without HBOT protection in high-risk cases
Re-irradiation for recurrence
Poor nutritional status, feeding-tube dependence, and chronic inflammation

The combination of high-dose mandibular radiation and a post-treatment extraction is the classic trigger for jaw osteoradionecrosis, which is why dental prophylaxis is so central in Canadian head and neck oncology programmes.

Why Is It Difficult to Treat?

Radiation leaves irradiated tissue hypoxic (oxygen-starved), hypovascular (poorly perfused), and hypocellular (repopulated by fewer viable cells). This “three-H” state is the textbook framework that still guides hyperbaric oxygen use in this population. Once damage occurs, normal wound healing cannot proceed because the tissue simply does not have the oxygen delivery and cellular activity required. This mechanism is common to all late radiation tissue injury; our delayed radiation injury overview explains the general clinical picture across the body, while this article focuses on how that damage presents and is managed specifically in the head and neck.

Treatment of established radiation damage in the head and neck therefore has two broad goals: restore enough oxygen and perfusion for healing to take place, and address the local mechanical or structural problem (exposed bone, fibrotic tissue, damaged nerve, fibrosed muscle). Each complication has its own package of management: dental conservation and fluoride for dry mouth, jaw-stretching devices for trismus, pentoxifylline and vitamin E for fibrosis, reconstructive surgery for refractory ORN, and so on. HBOT is one of the few interventions that targets the underlying hypoxia and hypovascularity at the tissue level.

The irradiated head and neck is a wound that the body cannot finish healing. Restoring oxygen delivery is the mechanical precondition for repair. That is the biological argument for HBOT in this population.

How Might HBOT Help?

Hyperbaric oxygen therapy delivers 100% oxygen at pressures typically between 2.0 and 2.4 atmospheres absolute (ATA). At this pressure, dissolved plasma oxygen increases roughly 14 to 18 times above baseline, enabling oxygen to reach tissues with compromised microcirculation. In the context of head and neck radiation damage, the mechanisms of interest include:

Angiogenesis: a course of HBOT (typically 30 to 40 sessions) promotes new capillary formation in chronically ischaemic irradiated tissue
Improved perfusion of the mandible, skull base, oral mucosa, and neck soft tissue
Anti-inflammatory effects modulating chronic radiation inflammation
Mobilisation of bone-marrow-derived stem cells, which participate in irradiated-tissue repair
Reduced tissue oedema and improved leucocyte function in the healing wound
Prophylactic effect when delivered around dental extractions in irradiated jaws, reducing the risk that a minor intervention triggers osteoradionecrosis

These are the same biological effects that support HBOT use in soft tissue radiation necrosis in the bladder, bowel, and chest wall. What makes the head and neck distinctive is the central role of the jaw and the specific role of dental extractions as a trigger.

What Does the Research Show?

Evidence for HBOT in head and neck radiation damage is among the deepest bodies of hyperbaric medicine literature. It spans randomised trials, systematic reviews, meta-analyses, and large retrospective cohorts. The strongest signal is for jaw osteoradionecrosis, with smaller but consistent signals for skull-base necrosis and soft-tissue radiation necrosis.

ISOO/MASCC/ASCO Clinical Practice Guideline (2024)

The joint International Society of Oral Oncology, Multinational Association of Supportive Care in Cancer, and American Society of Clinical Oncology published a clinical practice guideline on the prevention and management of osteoradionecrosis in patients with head and neck cancer treated with radiation therapy. This is the most widely referenced consensus guideline in the area and shapes the structure of many Canadian ORN programmes. The guideline supports HBOT in selected refractory ORN and includes detailed recommendations on dental assessment before radiotherapy, timing of extractions, and coordinated surgical management.

Overview of Systematic Reviews for Head and Neck ORN (2024)

A 2024 overview of systematic reviews for osteoradionecrosis treatment in head and neck cancer synthesised evidence across conservative, surgical, and adjunctive modalities. The overview confirmed that HBOT is supported by multiple systematic reviews as part of combined management, particularly when used alongside debridement or reconstructive surgery, and that quality of evidence ranges from moderate for prophylaxis to low-moderate for established refractory disease.

HBOT Meta-Analysis for Jaw Osteoradionecrosis (2021)

An evaluation of hyperbaric oxygen therapy for the osteoradionecrosis of the jaws (meta-analysis) pooled outcomes across randomised and observational studies. The meta-analysis supported HBOT as an adjunct with meaningful effect sizes in terms of mucosal healing, symptom reduction, and surgical success when HBOT was combined with debridement or reconstruction. The analysis also highlighted the heterogeneity of published protocols (ranging from 20 to 40 pre-surgical sessions, with 10 post-surgical sessions common) and underscored the need for standardisation.

Tooth-Extraction Prophylaxis (2024)

Dental extractions in irradiated jaws are a classic trigger for osteoradionecrosis. A 2024 systematic review on adjunctive modalities during tooth extraction for the prevention of osteoradionecrosis evaluated HBOT, pentoxifylline and vitamin E, platelet-rich fibrin, and other strategies. HBOT is one of the better-studied prophylactic approaches, particularly in high-risk patients with high mandibular doses, and is the standard-of-care prophylaxis at several Canadian centres when extractions cannot be avoided.

Skull-Base Osteoradionecrosis (2025)

A 2025 systematic review and meta-analysis on the presentation and optimal management of anterior and central skull-base osteoradionecrosis addressed this rarer, more serious form of head and neck radiation damage. The review identified combined surgical and HBOT management as the approach with the most favourable outcomes in refractory disease, while noting that individual cases require highly coordinated neurosurgical, otolaryngology, and hyperbaric medicine input.

Summary of the Evidence Base

Jaw osteoradionecrosis: strongest HBOT evidence base in all of radiation-injury medicine. Multiple meta-analyses and consensus guidelines support adjunctive use
Tooth-extraction prophylaxis in high-risk irradiated jaws: well-supported; one of the main indications for pre-emptive HBOT in Canadian centres
Skull-base ORN: smaller evidence base but combined surgical-HBOT approach favoured in severe disease
Soft-tissue radiation necrosis in the head and neck: supported by the Cochrane 2023 systematic review for late radiation tissue injury overall
Xerostomia and trismus: HBOT has been studied with mixed, mostly modest signals; not a primary indication
Dysphagia, cognitive, and hearing effects: evidence is limited; HBOT is not standard management for these on their own

What Canadian Patients Need to Know

Soft-tissue radiation necrosis and radiation damage affecting bone are both on Health Canada’s 14 recognised conditions for hyperbaric oxygen therapy. Head and neck osteoradionecrosis falls squarely within “radiation damage affecting bone”, and oral or pharyngeal soft-tissue necrosis falls within “soft tissue radiation necrosis”. Coverage is therefore generally available at hospital-based Canadian HBOT programmes for eligible patients, under a coordinated referral pathway.

Practical points for Canadian patients navigating head and neck radiation damage:

Dental workup comes first. Any planned or suspected jaw or oral problem should be assessed by a dentist or oral and maxillofacial surgeon familiar with irradiated patients before major interventions
Extractions should be done before radiotherapy where possible. If extractions are needed after, discuss pre- and post-operative HBOT with the treating oncology team
Coverage: hospital-based HBOT programmes can typically bill the provincial plan for osteoradionecrosis and soft-tissue radiation necrosis under a radiation-injury referral. See the HBOT coverage across Canada guide for province-specific detail; confirm eligibility with the treating centre
Typical protocol: roughly 20 to 30 pre-surgical sessions plus 10 post-surgical sessions (the Marx protocol) is the commonly cited reference. Protocols are set by the treating hyperbaric medicine physician based on the clinical scenario
Expect coordination: HBOT in this population is almost always combined with dental care, surgical debridement or reconstruction, and long-term follow-up
Self-pay is the alternative if hospital access is delayed or unavailable. Private Canadian clinic fees range roughly $150 to $350 per session, depending on chamber type and location

The Canada Hyperbarics facility directory lists hospital-based and private hyperbaric programmes across the country, including several centres with strong head and neck radiation-injury experience. Patients should ask any potential centre about experience with the specific complication in question (jaw ORN, skull-base ORN, soft-tissue necrosis, prophylaxis around extraction) and how they coordinate with dental, maxillofacial, and oncology teams.

Is HBOT Safe for Head and Neck Cancer Survivors?

HBOT is well tolerated in this population and has a long safety record in radiation-injury indications. Multiple safety reviews have concluded that HBOT does not promote tumour growth or recurrence. Because HBOT is an established treatment for late radiation tissue injury, its safety profile specifically in cancer survivors is among the best-characterised in hyperbaric medicine.

The typical side effects are mild and usually transient: middle-ear barotrauma from pressure changes (particularly relevant in head and neck patients whose Eustachian tube function can be affected by surgery or radiation), temporary myopia that resolves after treatment, confinement anxiety, and rare episodes of oxygen toxicity. Ear tubes (myringotomy) are sometimes placed before HBOT in patients with refractory ear pressure equalisation difficulties.

Patients with active or suspected malignancy in the treated field require oncology clearance before starting HBOT. Patients with uncontrolled pneumothorax, severe COPD with bullous disease, or recent ocular surgery require careful pre-treatment screening. A hyperbaric medicine physician assesses suitability for every patient as part of the intake process.

Frequently Asked Questions

How many HBOT sessions are typical for osteoradionecrosis of the jaw?

Most published programmes use a variant of the Marx protocol: approximately 20 to 30 pre-surgical sessions at 2.0 to 2.4 ATA, followed by surgical debridement or reconstruction, followed by roughly 10 post-surgical sessions. Specific protocol length is set by the treating hyperbaric medicine physician based on disease stage and surgical plan.

Will HBOT help if I have only dry mouth or jaw stiffness?

HBOT is not standard first-line treatment for xerostomia or trismus on their own. Standard care is salivary substitutes, fluoride, and dental conservation for xerostomia, and physiotherapy plus jaw-stretching devices for trismus. HBOT may be considered as part of a broader plan if these problems overlap with established ORN or soft-tissue radionecrosis.

Do I need HBOT before a dental extraction if I had head and neck radiation?

Not every patient needs it. Risk depends on the dose delivered to the extraction site, time since radiotherapy, tobacco use, and the specific tooth being extracted. Your oral and maxillofacial surgeon or hyperbaric medicine physician can estimate your individual risk and recommend a protocol if it is warranted.

Is HBOT covered by my provincial health plan for ORN?

HBOT for osteoradionecrosis and soft-tissue radiation necrosis is generally available under provincial coverage at hospital-based Canadian programmes for eligible patients. Referral pathways and eligibility vary by province and by centre. Confirm with the specific treating hyperbaric centre; the Canada Hyperbarics coverage guide summarises provincial rules.

Does HBOT reverse existing bone or tissue damage?

HBOT does not reverse bone or tissue that is already necrotic. What it can do is improve perfusion in the surrounding viable tissue, support surgical healing, reduce symptoms, and enable reconstruction that would otherwise fail. Realistic goals are symptom control, enabling surgery, and stabilisation, not regeneration of destroyed bone or mucosa.

Key Takeaway

Head and neck cancer radiation damage is a cluster of late complications, with jaw osteoradionecrosis the most clinically prominent. Evidence for hyperbaric oxygen therapy is among the strongest in hyperbaric medicine for this population: multiple meta-analyses and consensus guidelines support HBOT as adjunctive management, particularly around surgical debridement or reconstruction and as prophylaxis for high-risk dental extractions in irradiated jaws. Soft-tissue radiation necrosis is also well supported. HBOT is not a primary treatment for xerostomia or isolated trismus. Canadian patients should pursue HBOT in this setting through their treating oncology, dental, and hyperbaric medicine teams, with hospital-based programmes the usual route to provincially covered care. Canada Hyperbarics is an independent educational resource and has no affiliation with any specific clinic or manufacturer.

References

This content is for informational purposes only and does not constitute medical advice. Hyperbaric oxygen therapy for head and neck cancer radiation damage should only be considered within a coordinated plan involving the treating oncology, dental, maxillofacial, and hyperbaric medicine teams. Coverage and access vary by province and by treating centre. Canada Hyperbarics is an independent educational resource and is not affiliated with any specific clinic or manufacturer. Patients should consult their own clinicians before pursuing any HBOT-based treatment plan.

Back to All Articles

Head and Neck Cancer Radiation Damage and HBOT: What the Research Shows